Picture of TriSalus Life Sciences logo

TLSI TriSalus Life Sciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Annual balance sheet for TriSalus Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
R2023
December 31st
2024
December 31st
2025
December 31st
Period Length:
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments30.39.4111.88.5320.4
Net Total Accounts Receivable
Net Total Receivables1.361.563.555.096.56
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets35.117.220.920.732.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1.83.613.272.882.67
Net Intangible Assets
Other Long Term Assets
Total Assets37.82224.62435.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities6.3732.414.710.211.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities6.9334.351.749.969.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity30.9-12.3-27.1-25.9-33.9
Total Liabilities & Shareholders' Equity37.82224.62435.3
Total Common Shares Outstanding
Total Preferred Shares Outstanding